[{"id":"2a7ca647-6c30-4e9c-b1d6-666b4426ef4f","acronym":"","url":"https://clinicaltrials.gov/study/NCT05557591","created_at":"2022-09-28T17:01:05.693Z","updated_at":"2025-02-25T15:35:51.754Z","phase":"Phase 2","brief_title":"A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)","source_id_and_acronym":"NCT05557591","lead_sponsor":"Regeneron Pharmaceuticals","biomarkers":" PD-L1","pipe":"","alterations":" ","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Libtayo (cemiplimab-rwlc) • BNT116"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 04/21/2023","start_date":" 04/21/2023","primary_txt":" Primary completion: 03/02/2027","primary_completion_date":" 03/02/2027","study_txt":" Completion: 06/07/2027","study_completion_date":" 06/07/2027","last_update_posted":"2025-02-10"}]